Atkins H - Search Results

1

Bringing regenerative medicines to the clinic: the future for regulation and reimbursement.

Bubela T, McCabe C, Archibald P, Atkins H, Bradshaw SE, Kefalas P, Mujoomdar M, Packer C, Piret J, Raxworthy M, Soares M, Viswanathan S. Bubela T, et al. Among authors: atkins h. Regen Med. 2015;10(7):897-911. doi: 10.2217/rme.15.51. Epub 2015 Nov 13. Regen Med. 2015. PMID: 26565607 Free article. Review.

2

Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation.

Bubela T, Reshef A, Li MD, Atkins H, Caulfield T, Culme-Seymour E, Gold ER, Illes J, Isasi R, McCabe C, Ogbogu U, Piret J, Mason C. Bubela T, et al. Among authors: atkins h. Regen Med. 2012 Nov;7(6):735-40. doi: 10.2217/rme.12.59. Epub 2012 Oct 1. Regen Med. 2012. PMID: 23020169 Free article. No abstract available.

3

Is belief larger than fact: expectations, optimism and reality for translational stem cell research.

Bubela T, Li MD, Hafez M, Bieber M, Atkins H. Bubela T, et al. Among authors: atkins h. BMC Med. 2012 Nov 6;10:133. doi: 10.1186/1741-7015-10-133. BMC Med. 2012. PMID: 23131007 Free PMC article.

4

The global landscape of stem cell clinical trials.

Li MD, Atkins H, Bubela T. Li MD, et al. Among authors: atkins h. Regen Med. 2014 Jan;9(1):27-39. doi: 10.2217/rme.13.80. Epub 2013 Nov 18. Regen Med. 2014. PMID: 24236476 Free article.

5

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Fung M, Yuan Y, Atkins H, Shi Q, Bubela T. Fung M, et al. Among authors: atkins h. Stem Cell Reports. 2017 May 9;8(5):1190-1201. doi: 10.1016/j.stemcr.2017.03.013. Epub 2017 Apr 13. Stem Cell Reports. 2017. PMID: 28416287 Free PMC article.

6

Hematopoietic stem cell therapy for multiple sclerosis: top 10 lessons learned.

Atkins HL, Freedman MS. Atkins HL, et al. Neurotherapeutics. 2013 Jan;10(1):68-76. doi: 10.1007/s13311-012-0162-5. Neurotherapeutics. 2013. PMID: 23192675 Free PMC article. Review.

7

Five Questions Answered: A Review of Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Multiple Sclerosis.

Atkins HL, Freedman MS. Atkins HL, et al. Neurotherapeutics. 2017 Oct;14(4):888-893. doi: 10.1007/s13311-017-0564-5. Neurotherapeutics. 2017. PMID: 28822119 Free PMC article. Review.

8

Autologous Hematopoietic Stem Cell Transplantation in the Treatment of Multiple Sclerosis.

Rush CA, Atkins HL, Freedman MS. Rush CA, et al. Cold Spring Harb Perspect Med. 2019 Mar 1;9(3):a029082. doi: 10.1101/cshperspect.a029082. Cold Spring Harb Perspect Med. 2019. PMID: 29610145 Free PMC article. Review.

9

Another brick in the wall: further evidence supporting the role of haematopoietic stem cell transplantation in treating multiple sclerosis.

Atkins HL. Atkins HL. J Neurol Neurosurg Psychiatry. 2019 May;90(5):496. doi: 10.1136/jnnp-2018-319715. Epub 2019 Jan 10. J Neurol Neurosurg Psychiatry. 2019. PMID: 30630958 No abstract available.

10

The stem cell market and policy options: a call for clarity.

Zarzeczny A, Atkins H, Illes J, Kimmelman J, Master Z, Robillard JM, Snyder J, Turner L, Zettler PJ, Caulfield T. Zarzeczny A, et al. Among authors: atkins h. J Law Biosci. 2018 Nov 20;5(3):743-758. doi: 10.1093/jlb/lsy025. eCollection 2018 Dec. J Law Biosci. 2018. PMID: 31143461 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

551 results

Search Page